「japan」の検索結果
77件：56～60件目を表示
-
Research and Development System | Research & Development | SENJU Pharmaceutica
ackages based on sophisticated regulatory strategies while expanding development activities both in Japan and globally. That approach enables us to rapidly commercialize the compounds developed throug...
http://www.senju.co.jp/english/rd/about/ -
お知らせ | 千寿製薬株式会社
tion of 3in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained...
http://www.senju.co.jp/english/news/ -
お知らせ | 千寿製薬株式会社
bution of 3in1Smart and SPM-700（PDF） 2026年04月06日 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manuf...
http://www.senju.co.jp/chinese/news/ -
Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug des...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
研发产品管线 | 研究与开发 | 千寿制药株式会社
PROGRESS OF DEVELOPMENT 临床试验一期以后的公开信息 药品适应症状态（地区） SJP-0132Dry eyeLaunched（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeP3（China） SJP-0008Central Retinal Artery Occlu...
http://www.senju.co.jp/chinese/rd/pipeline.html